Cytokines in Behçet's disease

Journal of Rheumatology

Volumn 23, Issue 2, 1996, Pages 321-322

  Sayinalp, Nilgün ^a,b   Özcebe, Osman Ilhami ^a   Özdemir, Oktay ^a   Haznedaroǧlu, Ibrahim Celalettin ^a   Dündar, Semra ^a   Kirazli, Şerafettin ^a  

^a HACETTEPE UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

Autoimmunity; Beh ets disease; Cytokines

Indexed keywords

INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ADULT; ARTICLE; AUTOIMMUNITY; BEHCET DISEASE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; ADOLESCENT; AGING; BLOOD; ENZYME LINKED IMMUNOSORBENT ASSAY; MIDDLE AGED; PHYSIOLOGY; REFERENCE VALUE;

ADOLESCENT; ADULT; AGING; BEHCET SYNDROME; CYTOKINES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, INTERLEUKIN-2; REFERENCE VALUES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029662248     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Lehner T, Batchelor JR, Challecombe K, Kennedy L: An immunogenetic basis for tissue involvement in Behçet's syndrome. Immunology 1979;37:895-900.
2. Lehner T: Behçet's syndrome and auloimmunity. BMJ 1967;1:465-7.
3. Sakane T, Suzuki N, Ueda Y: Analysis of interleukin-2 activity in patients with Behçet's disease. Arthritis Rheum 1986;29:371-8.
4. Hamzaoui K, Hamza M, Ayed K: Production of TNF-α and IL-1 in active Behçet's disease. J Rheumatol 1990;17:1428-9.
5. Memişoǧlu H, Aksu HZS, Erken E, Göcük M: Serum interleukin-1 levels in Behçet's disease. In: O'Duffy JD, Kokmen E, eds. Behçet's Disease. Basic and Clinical Aspects. New York: Marcel Dekker, 1991:387-91.
6. Erken E, Aksu HSZ, Memişoǧlu H, Ersöz R, Erken U: Serum tumor necrosis factor alpha in Behçet's disease. In: O'Duffy JD, Kokmen E, eds. Behçet's Disease. Basic and Clinical Aspects. New York: Marcel Dekker, 1991:681-6.
7. Hamzaoui K, Ayed K: Soluble interleukin 2 receptors in patients with Behçet's disease. J Rheumatol 1989;16:852-3.
8. Akoǧlu T, Direskeneli H, Yazici H, Lawrence R: TNF, soluble IL-2R and soluble CDS in Behçet's disease. J Rheumatol 1990;17:1107-8.
9. Mege JL, Dilsen N, Sanguedolce V, et al: Overproduction of monocyte derived tumor necrosis factor α, interleukin (IL) 6, IL-8 and increased neutrophil superoxide generation in Behçet's disease. A comparative study with familial Mediterranean fever and healthy subjects. J Rheumatol 1993;20:1544-9.
10. International study group for Behçet's disease: Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078-80.
11. Oppenheim JJ, Ruscetti FW, Faltynek C: Cytokines. In: Sntes DP, Terr AI, eds. Basic and Clinical Immunology, 7th ed. Connecticut: Prentice Hall International 1991:78-100.
12. Sakane T, Kotani H, Takada S, Tsunematsu T: Functional aberration of T cell subsets in patients with Behçet's disease. Arthritis Rheum 1982;25:1343-51.
13. Grunfeld C, Palladino MA: Tumor necrosis factor: Immunologic, antitumor, metabolic and cardiovascular activities. Adv Intern Med 1990;35:45-72
14. Gehr G, Braun T, Lesslauer W: Cytokines, receptors and inhibitors. Clin Invest 1992;10:64-9.